1. A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal Of Rivaroxaban-Induced Anticoagulation In Healthy Subjects By Andexanet Alfa (PRT064445), An Antidote For Fxa Inhibitors
by Crowther Mark, Mathur Vandana, Kitt Michael, Lu Genmin, Pamela B. Conley, Hollenbach Stanley, Janice Castillo, Athiwat Hutchaleelaha, Mark Karbarz, Joyce P. Lin, Lee Barron, Sandra Russell, Gallia G. Levy, Stuart Connolly, and John T. Curnutte
Blood
Volume 122(21):
November 15, 2013
©2013 by American Society of Hematology

2. Mathur Vandana et al. Blood 2013;122:3636
©2013 by American Society of Hematology